Samsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and...
Samsung Bioepis Co., Ltd. announced the opening of its new headquarters in Korea’s ‘Bio Cluster’...
AbbVie’s Rinvoq receives European approval to treat active psoriatic arthritis
AbbVie announced that the EC has approved Rinvoq (upadacitinib, 15 mg), an oral, once daily...
Saudi Arabia to get three million AstraZeneca shots from India
The Serum Institute of India (SII) will supply Saudi Arabia with 3 million AstraZeneca COVID-19...
MedPharm Former CSO Marc Brown Champions Company Innovation in New Role
MedPharm Ltd, the world’s leading contract service provider of contract topical and transdermal product design...
Roche and Sysmex renew partnership to deliver haematology testing solutions
Roche announced that, on 14 December, 2020, it signed a Global Business Partnership Agreement (GBP)...
AstraZeneca’s Calquence gets Japanese approval to treat adult patients with relapsed/refractory CLL
AstraZeneca’s Calquence (acalabrutinib), a next-generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in...
Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial
Care Access Research, a decentralized research organization (DRO) that connects physicians and research experts, entered...
SPT Labtech Announces a Co-Marketing Initiative with Thermo Fisher Scientific to Help Reduce the...
The cost of library preparation is one of the biggest obstacles to large next-generation sequencing...
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help...
Pfizer and BioNTech SE announced an advance purchase agreement with COVAX for up to 40...
Ubiquigent and the University of York awarded grant to undertake neglected tropical diseases treatment...
Ubiquigent Limited (Ubiquigent) and the Mottram Laboratory at the University of York announced a collaboration...
